GPT and metabolic dysfunction-associated steatohepatitis: Based on these findings, a microRNA-based composite biomarker consisting of miR-192, miR-21, miR-505 and ALT was proposed, which demonstrated great performance in distinguishing between lean and NASH mice (NAS > 3).